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Kyoung Eun Lee1, Hak Hee Kim2*, Hee Jung Shin2 and Joo Hee Cha2Abstract
Purpose: To evaluate efficacy of the stereotactic vacuum-assisted breast biopsy(SVAB) using a decubitus table and
to compare histologic underestimation rate between 11gauge(G)- and 8G-probes.
Materials and methods: Pathologic results of SVAB using a decubitus table of 210(120 with 11G; 90
with 8G)-procedures in 208-women(median age, 48.8 years; range, 27-73 years) were retrospectively reviewed.
SVAB was performed for suspicious microcalcification without mass on MMG and US. Surgury was performed for
the diagnosis of malignant or high-risk lesion (65(31.0%)). Patients with benign diagnosis (120(57.1%)) underwent
MMG follow-up (mean, 340-days). Histologic underestimation was defined as the need to upgrade ADH to DCIS or
IDC, and DCIS to IDC at surgery. We analyzed the difference of procedure time, core number and core weight
between 11G- and 8G-groups. Statistical significance was determined with chi-square test and 95%-CI for
histologic underestimation, and student T-test for comparing two-groups.
Results: Targeting was successful in all 210-biopsies on specimen radiographs. Mean core number, core weight and
procedure time were 17.5 (17.5 ± 4.9), 1.57 g (1.57 ± 0.56), 34.5 min (34.5 ± 16.4) with 11G-probe, and 9.6 (9.6 ± 6.2),
1.83g (1.83 ± 0.93), 22.1 min (22.1 ± 12.5) with 8G-probe. Findings in 120 (57.1%) of the biopsies were benign, 36 (17.2%)
were high-risk, and 54 (25.7%) were malignant. Two (6.25%) of 32 cases of ADH were upgraded to DCIS in 11G-group,
and 2 (9.09%) of 22 in 8G-group. No case of DCIS was upgraded to IDC. There was no increase of complication in 8G-
group than 11G-group.
Conclusion: SVAB using a decubitus table is safe and effective method for the evaluation of suspicious
microcalcification, and there was no significant difference between 11G- and 8G-probes. But, SVAB with 8G-probe is
significantly more time efficient and effective procedure.
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Stereotactic vacuum-assisted breast biopsy (SVAB) is well-
established reliable, less invasive and cost effective method
alternative to traditional needle localization biopsy (Sigal-
Zafrani et al. 2008; Burbank 1997; Berg et al. 1997; Won
et al. 1999; Peters et al. 2008; Zuiani et al. 2007; Kettritz* Correspondence: hhkim@amc.seoul.kr
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in any medium, provided the original work is pet al. 2005; Diebold et al. 2005; Della Sala et al. 2004;
Jackman 2004; Kettritz et al. 2004; Han et al. 2003; Rotter
et al. 2003; Pandelidis et al. 2003; Liberman & Sama 2000).
Stereotactic biopsy can be performed with dedicated prone
system or add-on stereotactic unit (Georgian-Smith et al.
2002; Welle & Clark 1997; Sim & Kei 2008; Welle et al.
2000; Doyle et al. 1999). Dedicated prone systems are ex-
pensive and limited for one use, which guide needle and re-
quire significant space. Add-on units are less expensive and
used with conventional mammographic unit. It can be used
with the patient in the upright or lateral decubitus position.pen access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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and causes higher frequency of vasovagal reaction. So, a
technique using add-on stereotactic unit with the patient in
the decubitus position is used increasingly to avoid patient
movement and syncope (Welle et al. 2000; Doyle et al.
1999). Recently, the decubitus table (DBI™ table, Medical
Positioning Inc, Washington, Kansas, U.S.A.) has been de-
veloped and used with add-on stereotactic unit.
Increasing needle diameter of SVAB allows larger sam-
ples of tissue to be obtained. Increasing sample weights
has resulted significantly decreased rates of histologic up-
grade between 11- and 14-guage needles (Darling et al.
2000). But larger biopsy needle has not decrease the up-
grade rate of ADH between 9- and 11-gauge needles (Eby
et al. 2009). However, SVAB using an 8-gauge needle has
not been evaluated well on English literature.
So, the purpose of this study was to evaluate efficacy of
the stereotactic vacuum-assisted breast biopsy (SVAB)
procedure using a decubitus table and to compare proced-
ure time, core number, weight, complication rate, and
histologic underestimation rate between 11- and 8-gauge
(G) probes.
Materials and methods
We retrospectively reviewed data from 210 consecutive
SVAB procedures in consecutive 208 women (median
age, 49.8 years; range, 27-73 years) performed from June
2007 through May 2009. The study was approved by the
institutional review board of Asan Medical Center.
All SVAB biopsies were performed with a decubitus table
(DBI™ table, Medical Positioning Inc, Washington, Kansas,
U.S.A.). Total 120 biopsies were performed with an 11-
gauge probe (Mammotome, Biopsy/Ethicon endosurgery
Inc, a Johnson & Johnson Co., Cincinnati, OH, U.S.A.).
And total 90 biopsies were performed with an 8-gauge
probe (Mammotome, Biopsy/Ethicon endosurgery Inc, a
Johnson & Johnson Co., Cincinnati, OH, U.S.A.). MMG was
taken with a Senographe DS with a stereotactic add-on unit
(General Electric Medical System, Milwaukee, WI, U.S.A.).
The biopsy protocol and selection criteria for SVAB
were identical for the 11G and 8G groups. Pre-biopsy
medication restriction guidelines and routine post-biopsy
care (manual compression, dressing, ice pack, and elastic
band application) were also identical for these two groups.
Stereotactic biopsy was used for calcifications without def-
inite mass on MMG and no definite lesion on US. All bi-
opsy targets were BI-RADS category 4 or 5 lesions and
some 3 lesions which the patients want to biopsy. Lesion
size and density of breast parenchyma were not used as
criteria for exclusion from SVAB. Informed consent for bi-
opsy was obtained from each patient. Images were
obtained before and after the biopsy device were activated
to document accurate needle position in the targeted
lesion. Retargeting was performed if necessary. Biopsyspecimens were typically obtained in a 360° rotation
with the directional biopsy instrument, particularly when
needle placement was within the lesion. When MMG
obtained after the instrument was activated showed the
needle to be immediately adjacent to the lesion, cores were
obtained with the bowl of the needle directed toward the
lesion. Standard practice at our institution at the time of
the study was to obtain sufficient specimens to acquire ad-
equate calcifications on routine specimen radiography.
The radiologist assessed the specimen radiograph and
obtained additional cores as needed. Post-biopsy MMGs
were routinely obtained for the evaluation of residual calci-
fication. Lesion type, number of cores obtained, and path-
ology results were recorded by the radiologist performing
the procedure. Acute complications such as hematoma or
bleeding also were recorded.
Surgical excision was subsequently carried out for the
patients with the diagnosis of malignant or high-risk le-
sions on SVAB. Breast pathology was reviewed by two
pathologists. The patients with benign diagnosis under-
went MMG follow-up. The percentage of lesions diag-
nosed as ADH or DCIS at SVAB and the pathology
result at surgery were compared between the 8G and
11G biopsy groups. Histologic underestimation was de-
fined as the need to upgrade ADH to DCIS or IDC at
surgery and to upgrade DCIS to IDC. And we analyzed
the difference of total procedure time, core number and
core weight between 11G and 8G groups.
The number of samples of 8G and 11G specimen was
counted. The total weight of specimen was estimated by
sample number × average weight per specimen (0.09
gram; 11G, 0.19 gram; 8G).
Histologic underestimation rate and complication rate
for these two groups were analyzed for statistical signifi-
cance by use of the chi-square test. Statistical significance
was considered p < 0.05. The statistical calculations were
performed with statistical software (SAS version 9.1.3,
SAS Institute). The difference of total procedure time, and
number of obtained samples were evaluated by the stu-
dent T-test and 95% confidence interval.Results
The average of patient age was 48.8 years (range, 27–73
years) in the 11G group and 50.8 years (range, 30–72
years) in the 8G group. In the 11G group, 3 (2.50%) of the
MMG findings were BIRADS 3, 113 (94.17%) were
BIRADS 4, and 4 (3.33%) were BIRADS 5 lesions. In the
8G group, 2 (2.22%) of the MMG finding was BIRADS 3,
85 (94.44%) were BIRADS 4, and 3 (3.33%) were BIRADS
5 lesions. Sixty-five patients (31.0%) underwent surgical
excision. MMG follow-up was available for 113 (53.8%)
patients who did not undergo surgery (mean, 340 days).
Remained 32 patients were followed up loss.
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men radiographs. A mean of 17.5 (17.5 ± 4.9) specimens
per lesion were obtained with 11G probe and a mean of
9.6 (9.6 ± 6.2) specimens with 8G probe. The difference
in number of specimens obtained per lesion between the
11G and 8G groups was analyzed for statistical signifi-
cance with student T-test and was found statistically sig-
nificant (p < 0.0001). Mean specimen weight was 1.57 g
(1.57 ± 0.56) with 11G probe, and 1.83g (1.83 ± 0.93)
with 8G probe. And mean procedure time of SVAB was
34.5 min (34.5 ± 16.4) with 11G probe, and 22.1 min
(22.1 ± 12.5) with 8G probe. There were significant
differences in procedure time (p < 0.0001), core number
(p < 0.0001) and core weight (p < 0.0001).
Findings in 120 (57.1%) of the biopsies were benign,
36 (17.2%) were high-risk, and 54 (25.7%) were malig-
nant on SVAB.
SVAB using decubitus table was tolerable in all pa-
tients and there was no vasovagal reaction or major
complaint. Neither group had acute complications ne-
cessitating intervention. Two hematomas were reported
in the 11G group and 1 in the 8G group, none of which
required treatment. No infections were reported. And
there was no statistically significant difference of compli-
cation rate in two groups (P = 0.71).
We reviewed the SVAB biopsy database to identify 61
(29.0%) patients in whom pathologic evaluation of
stereotactic biopsy specimens yielded ADH or DCIS
during the study period. Then, medical records were
reviewed to determine the pathology result at final surgi-
cal excision. In 7 cases, surgical pathology reports were
not available, usually because the patient did not want to
undergo surgery or referred to other hospital. These
cases were excluded from analysis. So, the remaining 54
cases were included in the evaluation of histologic
underestimation rate.
On SVAB, 35 (29.17%) of 120 lesions were ADH or
DCIS in 11G group, and 3 cases were excluded. In
remaining 32 (26.7%) cases, 10 cases were ADH and 22
cases were DCIS. In 8G group, 26 (28.89%) of 90 lesions
were ADH or DCIS, and 4 cases were excluded. In
remaining 22 (24.4%) cases, 8 cases were ADH and 14
cases were DCIS.
In the 11G group, 2 (6.25%) ADH lesions were upgrade
to DCIS (Figure 1). In the 8G group, 2 (9.09%) cases were
upgraded with one ADH lesion to DCIS and another DCIS
lesion to IDC (Figure 2). The histologic underestimation
rates between the 11G and 8G groups were not statistically
different according to chi-square results (p = 0.706).
Discussion
Stereotactic vacuum-assisted breast biopsy (SVAB) is
used as an alternative method to the traditional needle-
localization biopsy on recent clinical practice (Sigal-Zafrani et al. 2008; Burbank 1997; Berg et al. 1997; Won
et al. 1999; Peters et al. 2008; Zuiani et al. 2007; Kettritz
et al. 2005; Diebold et al. 2005; Della Sala et al. 2004;
Jackman 2004; Kettritz et al. 2004; Han et al. 2003; Rotter
et al. 2003; Pandelidis et al. 2003; Liberman & Sama 2000).
It is well-known that SVAB is less invasive and cost
effective method for the evaluation of suspicious
microcalcification. And dedicated prone tables are well
accepted for SVAB, but higher cost and require larger
space, in addition to limited one use, which guide nee-
dle, prevent it to use widely. So, add-on stereotactic unit
is developed. But vasovagal reaction is more common with
the patient in the upright position. We used the decubitus
table (DBI™ table, Medical Positioning Inc, Washington,
Kansas, U.S.A.) which is recently developed for the use of
SVAB with the patient lying in the decubitus position.
Also, it has advantage that the patient movement is de-
creased due to comfortable position during procedure
than with the patient in the upright position (Welle &
Clark 1997; Welle et al. 2000; Doyle et al. 1999).
In our study, SVAB using a decubitus table was tolerable
in all patients. The patients were comfortable during pro-
cedure, which had eliminated patient motion, so lesion
targeting was successful in all SVAB. And there were no
patients who complain of a vasovagal reaction and no sig-
nificant immediate complication in this study.
Brem et al. (Brem et al. 2001) found that 8-gauge SVAB
showed a 39% increase in sample weight compared with
11-gauge SVAB. We used estimated weights of tissue
obtained with SVAB, which are 0.09 g with 11-gauge and
0.19 g with 8-gauge needle, to compare the obtained sam-
ple weight between two groups. Out result showed that
obtained sample numbers in 8G group were significantly
lower but sample weight were significantly heavier than
those of 11G group.
Histologic underestimation remains an issue on SVAB
in cases of ADH or DCIS, which are pathologic entities
of having common features in some portion. Sampling
error of SVAB can result histologic underestimation.
Surgery is recommended for the diagnosis of ADH on
SVAB to exclude the diagnosis of cancer. Darling et al.
(Darling et al. 2000) reported that the frequency of
histologic underestimation was substantially lower with
11G needle than with 14G needle. But, there are some
reports that there were no significant differences of
histologic underestimation rates between 11G and 9G
SVAB (Eby et al. 2009; Brem et al. 2001; Lourenco et al.
2007). Brem et al. (Brem et al. 2001) showed the result
that the accuracy of breast cancer diagnosis on SVAB
with 8G needle was greater in lesions smaller than
30 mm compared with that with 11G needle. Our study
showed similar result that there was no significant dif-
ference in histologic underestimation rate between 11G
and 8G groups (p = 0.706).
Figure 1 The case of histologic underestimation on SVAB with an 11-gauge needle. There are clustered coarse heterogeneous calcifications
in the right breast which is BIRAD category 4. The pathologic result was mucocele-like lesion with ADH on SVAB, but mucocele-like tumor with
DCIS on surgery.
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have been examined with MMG follow-up. All these le-
sions were stable during follow-up and none of these le-
sions have been subsequently proven to be malignancy.
Lomoschitz et al. (Lomoschitz et al. 2004) reported
that histologic underestimation rate was not increased
even if 12 samples rather than 20 samples per lesion
had been retrieved and highest diagnostic yield was
achieved at 11-gauge SVAB. Jackman et al. (Jackman
et al. 2001) found that DCIS underestimation was 1.5
times more frequent with 10 or fewer specimens per le-
sion were obtained on SVAB using 11G and 14G needle.
We found that histologic underestimation rate was not
increased even if 9.6 specimens, fewer than 10 speci-
mens per lesion, were obtained at SVAB using 8G nee-
dle compared with 11G needle. Specimen weight wasFigure 2 The case of histologic underestimation on SVAB with an 8-g
in the left breast which is BIRAD category 4. The pathologic result was ADH16.6% increased at 8G SVAB compared with 11G and the
difference was statistically significant. But we suggest that
it was not enough increase of specimen weight to decrease
histologic underestimation rate. In our study, the deter-
mining factor of obtained specimen number was adequate
retrieval of calcifications. It is more likely that more calcifi-
cations can be retrieved per specimen in 8-gauge SVAB,
so the average number of specimen is smaller in 8G group
than 11G group.
The limitation of our study include retrospective study
design, which cause many follow-up loss, the difference of
patient numbers between two groups - fewer 8G SVABs
were included than 11G SVABs -, not all patients with
ADH or DCIS on SVAB undergo surgery, and the amount
of retrieved calcifications were determined by each radi-
ologist who performed the SVAB procedure.auge needle. There are regional distributed amorphous calcifications
on SVAB, but DCIS on surgery.
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using a decubitus table is safe and effective method for the
evaluation of suspicious microcalcification. And there was
no statistically significant difference between 11G and 8G
needles in the diagnosis of suspicious microcalcification.
But, SVAB using an 8G probe is significantly more time ef-
ficient and effective procedure than using an 11G needle.
And further studies with larger patients and more long-
term follow-up are needed to evaluate the efficacy of larger
tissue obtaining device at percutaneous breast biopsy.
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